Effectiveness and safety of antiplatelet in stroke patients with end‐stage renal disease undergoing dialysis
ConclusionsAntiplatelet therapy, especially aspirin, still offers safe and effective treatment for ischemic stroke prevention in patients with end‐stage renal disease undergoing dialysis.
Source: International Journal of Stroke - Category: Neurology Authors: Chung‐Yu Chen, Kun‐Tai Lee, Charles Tzu‐Chi Lee, Wen‐Ter Lai, Yaw‐Bin Huang Tags: Research Source Type: research
More News: Aspirin | Bleeding | Clopidogrel | Databases & Libraries | Diabetes | Diabetes Mellitus | Dialysis | Endocrinology | Health Insurance | Heart Attack | Insurance | Ischemic Stroke | Neurology | Plavix | Stroke